Skip to main content

Peer Review reports

From: Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family

Original Submission
31 Oct 2022 Submitted Original manuscript
19 Nov 2022 Reviewed Reviewer Report
3 Dec 2022 Reviewed Reviewer Report
24 Dec 2022 Author responded Author comments - Li-Hui Wang
Resubmission - Version 2
24 Dec 2022 Submitted Manuscript version 2
4 Jan 2023 Author responded Author comments - Li-Hui Wang
Resubmission - Version 3
4 Jan 2023 Submitted Manuscript version 3
12 Jan 2023 Author responded Author comments - Li-Hui Wang
Resubmission - Version 4
12 Jan 2023 Submitted Manuscript version 4
18 Jan 2023 Reviewed Reviewer Report
18 Jan 2023 Reviewed Reviewer Report
6 May 2023 Author responded Author comments - Li-Hui Wang
Resubmission - Version 5
6 May 2023 Submitted Manuscript version 5
27 May 2023 Author responded Author comments - Li-Hui Wang
Resubmission - Version 6
27 May 2023 Submitted Manuscript version 6
6 Jun 2023 Reviewed Reviewer Report
8 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
8 Jul 2023 Editorially accepted
18 Jul 2023 Article published 10.1186/s12885-023-11165-x

You can find further information about peer review here.

Back to article page